Results 11 to 20 of about 164,783 (254)
The Egyptian Journal of Neurology, Psychiatry and Neurosurgery, 2021 Background The incidence of thyroid dysfunction in multiple sclerosis (MS) patients on interferon (as a disease-modifying line) has been reported in many studies performed on patients already on interferon therapy.
Farouk Talaat, Hany Eldeeb
doaj +1 more source
Acta Biomedica Scientifica, 2020 Background. The ability to control regeneration processes is a key link in the development of methods for treating patients with post-traumatic disorders of reparative osteogenesis. Aim of the study.
V. F. Lebedev +3 more
doaj +1 more source
Безопасность и риск фармакотерапии, 2019 Multiple sclerosis is one of the most common neurological diseases of working age population. The last 20 years widely use drugs that change the course of multiple sclerosis.
K. E. Zatolochina +3 more
doaj +1 more source
مجله دانشکده پزشکی اصفهان, 2018 Background: Treatment has a major effect on attacks in patients with multiple sclerosis (MS). This study aimed to determine the effect of the type of used drug on occurrence and number of attacks in patients with multiple sclerosis.
Marjan Jamalian +4 more
doaj +1 more source
Arquivos de Neuro-Psiquiatria, 2008 Beta-interferon use in definite multiple sclerosis (MS) has been proven to modify clinical and magnetic resonance imaging outcome. We review and summarize the data of published double-blind, randomized clinical trials to assess, with a meta-analysis the ...
Ailton Melo +2 more
doaj +1 more source
Therapeutic Advances in Neurological Disorders, 2011 Interferon beta preparations are the most widely used initial therapies prescribed for patients with relapsing–remitting multiple sclerosis. Phase III studies have demonstrated comparable efficacy on clinical measures of disease activity, variable ...
Volker Limmroth +2 more
doaj +1 more source
مجله دانشکده پزشکی اصفهان, 2018 Background: Multiple sclerosis (MS) is a demyelinating inflammatory disease of central nervous system. Avascular necrosis (AVN) of femoral head is reported as an unusual complaint of multiple sclerosis.
Pegah Sadat Fatehi, Masoud Etemadifar
doaj +1 more source
Immunotherapy With Interferon α11, But Not Interferon Beta, Controls Persistent Retroviral Infection
Frontiers in Immunology, 2022 Type I Interferons (IFNs), including numerous IFNα subtypes and IFNβ, are key molecules during innate and adaptive immune responses against viral infections.
Mara Schwerdtfeger +11 more
doaj +1 more source
THE PROBLEM OF NEUTRALIZING ANTIBODIES IN MANAGEMENT OF MULTIPLE SCLEROSIS
Педиатрическая фармакология, 2011 It is known that the interferon beta therapy is more effective for multiple sclerosis. The literature review focuses on the problem of neutralizing antibodies (NAbs) in interferon beta therapy of multiple sclerosis for children and adolescents.
B.I. Bursagova +3 more
doaj +2 more sources
Some biological properties of the human amniotic membrane interferon
Memorias do Instituto Oswaldo Cruz, 1992 Human amniotic interferon was investigated to define the species specificity of its antiviral action and compare its anti-cellular and NK cell stimulating activities with those of other human interferons.
P. C. P. Ferreira +3 more
doaj +1 more source